Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: A systematic overview
- 31 August 2006
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 152 (2) , 291-296
- https://doi.org/10.1016/j.ahj.2006.03.027
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- C-Reactive-Protein-Associated Increase in Myocardial Infarct Size After Ischemia/ReperfusionThe Journal of Pharmacology and Experimental Therapeutics, 2002
- C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial InfarctionThe Journal of Experimental Medicine, 1999
- Myocardial Infarction and Apoptosis After Myocardial Ischemia and ReperfusionCirculation, 1998
- C-reactive protein and complement in myocardial infarction and postinfarction heart failureEuropean Heart Journal, 1997
- C-Reactive Protein Colocalizes With Complement in Human Hearts During Acute Myocardial InfarctionCirculation, 1997
- Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.Journal of Clinical Investigation, 1995
- Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusionEuropean Heart Journal, 1994
- Complement activation during cardiopulmonary bypass in infants and childrenThe Journal of Thoracic and Cardiovascular Surgery, 1993
- Detection of the terminal complement complex in patient plasma following acute myocardial infarctionAtherosclerosis, 1988
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981